Trial intelligence / Profile preview

Randomized phase II of CCNU versus CCNU + dasatinib in recurrent glioblastoma

2009-010576-21Phase 2Completed

Sponsor

Bristol Myers Squibb

Start

Jul 2009

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1